News for Inhibrx, Inc. (INBX)

INBX's two main pipeline candidates are entering critical late-stage trials with data readouts expected in mid- to late-2025. Click here to read my analysis.

Global Hyaluronic Acid Market Size, Share & Trends Analysis Report By Grade (Cosmetic Grade, Food Grade, Pharmaceutical Grade), By Application (Aesthetics,...

Advancements and Projections in the Pharmaceutical Intermediates Market: Insights, Trends, Opportunities, and Recent Developments...

Although U.S. stocks closed mixed on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the compa...

Inhibrx Biosciences (INBX) stock gains as CEO purchases 40K shares, raising stake by 5%. Read more here.

ISCG is a passively managed investment vehicle focused on small-cap stocks with appealing growth characteristics. See why the Fund is a Hold.

Earnings call: Lazard announced a net revenue increase to $1.4 billion

Inhibrx stock rated 'Market Perform' by JMP after Sanofi acquisition

Kamada (KMDO stock turned higher as Stifel initiated coverage with a buy rating, highlighting its R&D program targeting a rare lung disorder called AATD. Read more here.

Inhibrx biosciences director buys shares worth over $997,000

Spin-off Links - May 2024 By my count, there have been 7 new US spin-off announcements in 2024. Meanwhile 4 new spin-offs have started trading in the US YTD. Performance as measured by the S&P Spin-off ETF (CSD) has been quite strong with a YTD total return of 12.7% comparing favorably to the SPY. This

NEW YORK, May 10, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches...

NEW YORK, March 26, 2024 /PRNewswire/ -- Monteverde & Associates PC , has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services...

NEW YORK, March 18, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

NEW YORK, March 16, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

France's Sanofi to buy U.S. drugs project INBRX-101 for about $2.2 billion

Rapid growth of the medical imaging industry, increasing preference of personalized medicines and Research & Development (R&D) activities & government...

The dynamics of the osteosarcoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising...

The prevalence of mesothelioma has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence...